92 related articles for article (PubMed ID: 2658394)
1. [Does Hepavis have value in the therapy of fatty liver caused by alcohol poisoning?].
Odegaard S; Busch D
Z Gastroenterol; 1989 Feb; 27(2):91-3. PubMed ID: 2658394
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of alcoholic toxic fatty liver. A placebo-controlled trial with hepavis (author's transl)].
Deynet G; Reimer F
MMW Munch Med Wochenschr; 1979 Jun; 121(24):831-2. PubMed ID: 111085
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experience report on Hepavis].
Menninger U; Menninger W
Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534
[No Abstract] [Full Text] [Related]
4. [Reflections on medicamentous liver-therapy. Hepavis in medical practice].
Wegener W
Med Monatsschr; 1977 Jul; 31(7):328-30. PubMed ID: 904570
[No Abstract] [Full Text] [Related]
5. [Clinical experience with the oral liver-therapeutic agent Hepavis].
Bayazid A; Gerhard W
Med Welt; 1976 Nov; 27(46):2248-9. PubMed ID: 794616
[No Abstract] [Full Text] [Related]
6. [Treatment with Hepavis, a new cholerectically-active hepaticum. Experiences from an internal medicine profemoral practice].
Stuchlik S
Med Monatsschr; 1977 Nov; 31(11):524-6. PubMed ID: 927326
[No Abstract] [Full Text] [Related]
7. [Repair, regeneration and metabolism of liver cells: a clinical report].
Blasy J
ZFA (Stuttgart); 1979 Apr; 55(12):787-91. PubMed ID: 375610
[No Abstract] [Full Text] [Related]
8. [Drug therapy of liver diseases with Hepatofalk].
Hirsch W; Smerlings H
Ther Ggw; 1976 Oct; 115(10):1719-54. PubMed ID: 136762
[No Abstract] [Full Text] [Related]
9. [Non-alcoholic steato-hepatitis].
Linhart HG
Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
[TBL] [Abstract][Full Text] [Related]
10. [Controlled clinical trial of a new combination of phosphorylcholine, homocysteine-gamma-thiolactone and vitamin B 12 in the parenteral treatment of chronic hepatopathies].
Bandini S; Monteforte S
Clin Ter; 1974 Jun; 69(6):549-60. PubMed ID: 4845637
[No Abstract] [Full Text] [Related]
11. [Therapeutic progress in chronic liver diseases].
Wildhirt E
Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):207-8. PubMed ID: 4894834
[No Abstract] [Full Text] [Related]
12. [Double-blind study in patients with alcoholic toxic fatty liver. Effect of essential phospholipids on enzyme behavior and lipid composition of the serum].
Knüchel F
Med Welt; 1979 Mar; 30(11):411-6. PubMed ID: 372726
[No Abstract] [Full Text] [Related]
13. [The effect and tolerance of a gall-enzyme preparation].
Gross W; Kaiser HJ
Med Welt; 1978 Jan; 29(4):144-9. PubMed ID: 345040
[No Abstract] [Full Text] [Related]
14. [Effect of vitamin B12 and folic acid on protective effect of orotic acid].
Pates MM; Buiakovskaia OA; Kurkina VS; Pavlov GT; Pomerantseva II; Tunitskaia TA; Turetskaia IM; Tseitina AIa
Farmakol Toksikol; 1969; 32(5):604-7. PubMed ID: 5364684
[No Abstract] [Full Text] [Related]
15. [Disorders of vitamin B12 absorption in exocrine pancreatic insufficiency. Substitution treatment using Gillazym].
Herzfeld U; Kaess H
Med Welt; 1973 Jan; 24(2):48-50. PubMed ID: 4610314
[No Abstract] [Full Text] [Related]
16. [Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study].
Sergiacomo L; Ciancaglini R; Orlando D; Delle Monache G; Pesa O
Clin Ter; 1986 Oct; 119(2):133-41. PubMed ID: 3539468
[No Abstract] [Full Text] [Related]
17. [Essential phospholipids in the treatment of alcohol-induced steatosis and hepatitis].
Katuscák I; Hendrich F; Vladár L; Valentík M; Horáková M; Lauko L
Cas Lek Cesk; 1988 Apr; 127(18):556-9. PubMed ID: 3293785
[No Abstract] [Full Text] [Related]
18. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy.
Depew W; Boyer T; Omata M; Redeker A; Reynolds T
Gastroenterology; 1980 Mar; 78(3):524-9. PubMed ID: 6985881
[TBL] [Abstract][Full Text] [Related]
19. [Epomediol treatment of fatty liver in alcohol abuse. A controlled clinical double-blind study].
Pierri G; Giorgio A; Amoroso P; Fico P; Finelli L
Clin Ter; 1985 Mar; 112(6):527-35. PubMed ID: 3893863
[No Abstract] [Full Text] [Related]
20. Palmitoyl-catechin for alcoholic liver disease: results of a three-month clinical trial.
World MJ; Ryle PR; Aps EJ; Shaw GK; Thomson AD
Alcohol Alcohol; 1987; 22(4):331-40. PubMed ID: 3322310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
